Because of this, and the high frequency of MMR-defective melanoma cell line (1 out of 11), down-regulation or impaired MMR might be considered (together with up-regulation of MGMT) a cause of acquired resistance to TMZ and other methylating drugs. Here, MRC1 is linked to melanoma.